✦ LIBER ✦

Comparative efficacy and safety of the novel oral anticoagulants dabigatran, rivaroxaban and apixaban in preclinical and clinical development

✍ Scribed by Ufer, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Meta-Analysis of Efficacy and Safety of

✍ Corey S. Miller; Sonia M. Grandi; Avi Shimony; Kristian B. Filion; Mark J. Eisen 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 926 KB

Stroke prevention in patients with atria

✍ Lanitis, T.; Cotté, F. E.; Gaudin, A. F.; Kachaner, I.; Kongnakorn, T.; Durand-Z 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 611 KB

Recommendations for the emergency manage

✍ Steiner, T.; BÃ¶hm, M.; Dichgans, M.; Diener, H.-C.; Ell, C.; Endres, M.; Epple, 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 319 KB

The Cost-Effectiveness of Apixaban Compa

✍ Kelly, J.; Griffith, G.; Fortune, P.; Lister, S. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

C0227 Indirect comparison of the efficac

✍ Marx, Svetlana; Weiss, Christel; Wehling, Martin; Scharf, Hanns-Peter; Dahl, Ola 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Evaluating the efficacy and safety of ap

✍ Villa, Lorenzo A.; Malone, Daniel C.; Ross, Daniel 📂 Article 📅 2013 🏛 Carden Jennings Publishing 🌐 English ⚖ 229 KB